Generative Lead Optimization
Binding Affinity Prediction
Comprehensive Property Prediction
Technology Platforms
KINET is LexBio's AI-driven intelligent computing platform which integrates the state-of-the-art machine learning solutions, the high-end computing environment, and the user-friendly API to provide a digital laboratory for one-stop experimentation of predictive modeling, virtual screening and molecular generation.
Ultra-large Library for Hit Finding
3D Molecular Generation
Structural Filter
LexMolDB
LexBAP
LexMolProp
LexGen3D
LexFilter
LexOPT
Invited Presentations
2025 CBA-China Annual Conference.Dr. Li Xing was invited to give a talk of“Al accelerated antibody discovery”.
2025-07-04
Dr. Li Xing was invited as a special guest to host the early R&D forum and present a keynote speech on the topic of " Applications of AI Accelerated Antibody Discovery" in the 2024 BIO CHINA Congress.
2024-03-20
2024 ESMO TAT Congress was held in Paris, France, on Feb 26-28, 2024. Dr. Li Xing was invited to present "HIGHLY POTENT AND SELECTIVE RET INHIBITORS THAT OVERCOME ADAPTIVE DRUG RESISTANCE".
2024-03-11
SAPA-China 2023 Annual Conference and 30th Anniversary Celebration .Dr. Li Xing was invited to give a talk of “Apply deep learning (DL) to discover cancer treatments that overcome drug resistance”.
2023-11-09
Dr. Li Xing, CEO of LexBio, was invited as a special guest to present a keynote speech on the topic of "The Application of AI Technology in the Small Molecule Drug Discovery".
2023-09-27
Dr. Li Xing delivered a keynote speech in the "Antibody Upstream and Downstream Processes" session, sharing insights on "Opportunities in Accelerating Antibody Discovery with Artificial Intelligence".
2023-09-27
Dr. Xing was invited to share "AI accelerated discovery of novel cancer therapies that overcome drug resistance". The Forum brings together executives and experts of the world to share key opinions.
2023-09-27
|
|
E-mail:
contact@lexbiotx.com
Address:
218 Xinghu St. C17-409, Suzhou Industrial Park, Jiangsu, China